ArticleInternational journal of molecular sciences2019

Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy.

Damaris A Schillingmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.